Assistant Professor of Neurology
Dr. Fang earned a B.S. degree, with Distinction, from Pennsylvania State University in 1989 and received his M.D. from Jefferson Medical College in 1991. He completed an internship in Internal Medicine at Bryn Mawr Hospital in Bryn Mawr, PA. (1991-92) and performed his residency in Neurology at Thomas Jefferson University Hospital in Philadelphia, PA. (1992-95), where he was Chief Resident.
From 1995-98, Dr. Fang served in the Public Health Service, working in the Clinical Pharmacology Section of the Experimental Therapeutics Branch of the National Institute of Neurologic Disorders and Stroke. At Vanderbilt since 1998, Dr. Fang has continued to focus on the treatment of early Parkinson's disease and other movement disorders. He is also a staff physician at the Nashville Veterans Administration Medical Center.
My research interest is in the treatment of Parkinson's disease (and other movement disorders) and in particular conducting clinical trials to delay the progression to disability in neurodegenerative conditions. Current treatments of Parkinson's disease gradually become less effective over time. Through both local and international studies, my work is geared towards identifying interventions early on that may prevent treatments from becoming less effective. Additionally, identification of markers of disease and disease severity may allow simpler studies to be done at lower cost. Studying the use of technologies that may allow better diagnosis and treatment over time.
1: Pallavaram S, Phibbs FT, Tolleson C, Davis TL, Fang J, Hedera P, Li R, Koyama
T, Dawant BM, D'Haese PF. Neurologist Consistency in Interpreting Information
Provided by an Interactive Visualization Software for Deep Brain Stimulation
Postoperative Programming Assistance. Neuromodulation. 2013 May 3.
2: Tolleson CM, Fang JY. Advances in the mechanisms of Parkinson's disease.
Discov Med. 2013 Jan;15(80):61-6.
3: Zesiewicz TA, Sullivan KL, Hinson V, Stover NP, Fang J, Jahan I, Miller A,
Carranza MA, Elble R. Multisite, double-blind, randomized, controlled study of
pregabalin for essential tremor. Mov Disord. 2013 Feb;28(2):249-50.
4: Rao AS, Dawant BM, Bodenheimer RE, Li R, Fang J, Phibbs F, Hedera P, Davis T.
Validating an objective video-based dyskinesia severity score in Parkinson's
disease patients. Parkinsonism Relat Disord. 2013 Feb;19(2):232-7.
5: Yu H, Hedera P, Fang J, Davis TL, Konrad PE. Confined stimulation using dual
thalamic deep brain stimulation leads rescues refractory essential tremor: report
of three cases. Stereotact Funct Neurosurg. 2009;87(5):309-13.